Search results
Newswise Expert | Debora Bruno, Case Western Reserve University
Newswise· 2 days agoDr. Bruno is a medical oncologist and clinical researcher with a focus on lung cancer and other thoracic malignancies such as thymomas/thymic carcinomas as well as mesothelioma. As such, she ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 6 days agoSeer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased ...
Quanterix keeps Hold rating, steady stock target on strategic advantages By Investing.com
Investing.com· 21 hours agoOn Friday, TD (TSX:TD) Cowen maintained its Hold rating on Quanterix Corp. (NASDAQ:QTRX) with a...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoMerus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today ...
Thrombectomy Less Beneficial in Large-Core Stroke
Medscape· 1 day agoA secondary analysis of the SELECT2 trial suggests that large-core ischemic stroke patients with the greatest volume of tissue injury may benefit less from thrombectomy.
Early Memory Problems Linked to Increased Tau
Medscape· 1 day agoSelf- and partner reports of early memory issues are associated with higher levels of tau tangles, even before detectable clinical symptoms.
Danaher names Martin Stumpe as chief data and AI officer
MedTech Dive via Yahoo Finance· 2 days agoAt Tempus, Stumpe helped to build an AI and data science department to support activities such as...
Mediterranean Diet Can Lower Mortality Risk for Women, What to Know
Healthline via AOL· 5 days agoThe findings were published in JAMA Network Open on May 31. Researchers looked at health information...
Agilent (A) Boosts Reach to Lab Researchers With New Devices
Zacks via Yahoo Finance· 2 days agoAgilent (A) boosts its presence in the mass spectrometry market with the launch of the Agilent 7010D...
Tempus launches new HER2 and FOLR1 testing solutions
Medical Device Network via Yahoo Finance· 5 days agoTempus oncology chief medical officer Ezra Cohen said: “Expanding our offerings to include tests for specific, predictive biomarkers, like HER2, can help...
